EE200000657A - Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon - Google Patents

Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon

Info

Publication number
EE200000657A
EE200000657A EEP200000657A EEP200000657A EE200000657A EE 200000657 A EE200000657 A EE 200000657A EE P200000657 A EEP200000657 A EE P200000657A EE P200000657 A EEP200000657 A EE P200000657A EE 200000657 A EE200000657 A EE 200000657A
Authority
EE
Estonia
Prior art keywords
pharmaceutical
azoles
preparation
pharmaceutical composition
composition
Prior art date
Application number
EEP200000657A
Other languages
English (en)
Inventor
Jozef Elisabeth Van Der Veken Louis
Meerpoel Lieven
Jacobus Josef Backx Leo
Christopher Odds Frank
Heeres Jan
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200000657A publication Critical patent/EE200000657A/et
Publication of EE04311B1 publication Critical patent/EE04311B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200000657A 1998-05-14 1999-05-06 Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon EE04311B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201588A EP0957101A1 (en) 1998-05-14 1998-05-14 Water soluble azoles as broad-spectrum antifungals
PCT/EP1999/003243 WO1999058530A1 (en) 1998-05-14 1999-05-06 Water soluble azoles as broad-spectrum antifungals

Publications (2)

Publication Number Publication Date
EE200000657A true EE200000657A (et) 2002-04-15
EE04311B1 EE04311B1 (et) 2004-06-15

Family

ID=8233724

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200000651A EE04346B1 (et) 1998-05-14 1999-05-06 Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EEP200000657A EE04311B1 (et) 1998-05-14 1999-05-06 Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP200000651A EE04346B1 (et) 1998-05-14 1999-05-06 Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon

Country Status (32)

Country Link
US (2) US6384030B1 (et)
EP (3) EP0957101A1 (et)
JP (2) JP2002514646A (et)
KR (2) KR100575147B1 (et)
CN (2) CN1135229C (et)
AR (2) AR016482A1 (et)
AT (2) ATE238296T1 (et)
AU (2) AU751135B2 (et)
BG (2) BG64388B1 (et)
BR (2) BR9911057A (et)
CA (2) CA2331141C (et)
CO (1) CO5021227A1 (et)
CZ (2) CZ299481B6 (et)
DE (2) DE69907171T2 (et)
DK (1) DK1077976T3 (et)
EE (2) EE04346B1 (et)
ES (2) ES2198915T3 (et)
HK (2) HK1032781A1 (et)
HR (2) HRP20000741B1 (et)
HU (2) HUP0102031A3 (et)
IL (2) IL139647A0 (et)
MY (2) MY120248A (et)
NO (2) NO319851B1 (et)
NZ (2) NZ507965A (et)
PL (2) PL194086B1 (et)
PT (1) PT1077976E (et)
SI (1) SI1077976T1 (et)
SK (2) SK286156B6 (et)
TR (2) TR200003323T2 (et)
TW (2) TWI259835B (et)
WO (2) WO1999058530A1 (et)
ZA (2) ZA200007173B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
PL365072A1 (en) * 2000-03-07 2004-12-27 Ranbaxy Laboratories Limited Azole compounds as therapeutic agents for fungal infections
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
AR052342A1 (es) * 2004-12-21 2007-03-14 Janssen Pharmaceutica Nv Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores
CN102906087B (zh) * 2010-05-19 2016-03-23 桑多斯股份公司 制备手性三唑酮的方法
WO2013036866A1 (en) * 2011-09-07 2013-03-14 The Johns Hopkins University Itraconazole analogs and use thereof
US11028078B2 (en) 2011-09-07 2021-06-08 The Johns Hopkins University Itraconazole analogs and use thereof
KR102240329B1 (ko) 2013-06-07 2021-04-14 더 스크립스 리서치 인스티튜트 섬유증의 소분자 억제제
KR102579848B1 (ko) 2014-12-05 2023-09-18 풀모사이드 리미티드 항진균 화합물
WO2016094570A1 (en) * 2014-12-10 2016-06-16 The California Institute For Biomedical Research Small molecule inhibitors of fibrosis
CA2981945C (en) * 2015-05-21 2023-08-29 Pulmocide Limited Antifungal 4-(4-(4-(((3r,5r)-5-((1 h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl) benzamide, or a pharmaceutically acceptable salt thereof
CN105237392B (zh) * 2015-11-24 2017-12-12 辽宁渤大化工有限公司 芳烷基水杨酸及其衍生物的制备方法
US11390613B2 (en) 2017-08-20 2022-07-19 University Of Connecticut Azole analogues and methods of use thereof
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
ES2158859T3 (es) * 1992-03-18 2001-09-16 Janssen Pharmaceutica Nv Estereoisomeros itraconazol y saperconazol.
CO4520281A1 (es) * 1993-12-21 1997-10-15 Schering Corp Antifungicos de tetrahidrofurano
HU227281B1 (en) * 1994-01-24 2011-01-28 Janssen Pharmaceutica Nv Watersoluble azole antifungals, process for their preparation intermediates, and pharmaceutical compositions containing the compounds
FI98688C (fi) * 1994-07-20 1997-07-25 Nokia Telecommunications Oy Menetelmä lyhytsanomalähetyksen käynnistämiseksi solukkoradiojärjestelmässä, solukkoradiojärjestelmä sekä solukkoradiojärjestelmän tilaajarekisteri
IL118464A (en) * 1995-06-02 2000-08-13 Schering Corp (2R-cis)-4-¬4-¬4-¬4¬¬-5-(2',4 dihalophenyl)-tetrahydro-5-(1-H-1,2,4,triazol-1-yl-methyl)furan-3-yl(methoxy¾phenyl¾-1-piperazinyl¬phenyl2,4,dihydro2¬(5)-1-ethyl-2-(5)hydroxy propyl¾-3H-1,2,4-triazol-3-one and pharmaceutical compositions comprising them
MX9710270A (es) * 1995-06-19 1998-08-30 Schering Corp Fungicidas de tetrahidrofurano.
BR9809744A (pt) * 1997-02-11 2000-06-20 Janssen Pharmaceutica Nv Antifúngicos de azol contendo éster de aminoácido
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Also Published As

Publication number Publication date
EP0957101A1 (en) 1999-11-17
CN1137118C (zh) 2004-02-04
EP1077975B1 (en) 2003-04-23
ZA200007173B (en) 2002-03-04
BG64954B1 (bg) 2006-10-31
BG104717A (en) 2001-07-31
EP1077976A1 (en) 2001-02-28
SK285763B6 (sk) 2007-07-06
EE04346B1 (et) 2004-08-16
SK286156B6 (sk) 2008-04-07
US6384030B1 (en) 2002-05-07
AU751135B2 (en) 2002-08-08
EE04311B1 (et) 2004-06-15
HRP20000740A2 (en) 2001-10-31
KR100575147B1 (ko) 2006-05-03
HUP0102031A2 (hu) 2002-05-29
DE69907171T2 (de) 2004-02-05
HRP20000741B1 (en) 2009-02-28
AU4141799A (en) 1999-11-29
TR200003322T2 (tr) 2001-02-21
CN1300288A (zh) 2001-06-20
PL344037A1 (en) 2001-09-24
WO1999058529A1 (en) 1999-11-18
NO20005712D0 (no) 2000-11-13
PL344047A1 (en) 2001-09-24
HK1032781A1 (en) 2001-08-03
ATE238296T1 (de) 2003-05-15
SK16812000A3 (sk) 2001-08-06
AR016480A1 (es) 2001-07-04
KR20010041480A (ko) 2001-05-25
SI1077976T1 (en) 2003-02-28
EP1077976B1 (en) 2002-08-07
CZ20004109A3 (en) 2001-05-16
CZ299481B6 (cs) 2008-08-13
CO5021227A1 (es) 2001-03-27
BR9911057A (pt) 2001-02-06
NO20005713L (no) 2001-01-11
CN1135229C (zh) 2004-01-21
BG64388B1 (bg) 2004-12-30
EP1077975A1 (en) 2001-02-28
WO1999058530A1 (en) 1999-11-18
AU758876B2 (en) 2003-04-03
CA2331141C (en) 2008-10-28
ZA200007459B (en) 2002-09-13
BR9910448A (pt) 2001-01-02
ES2182531T3 (es) 2003-03-01
ES2198915T3 (es) 2004-02-01
CZ20004108A3 (en) 2001-05-16
ATE221884T1 (de) 2002-08-15
EE200000651A (et) 2002-04-15
NO20005713D0 (no) 2000-11-13
NZ507965A (en) 2002-05-31
AU4361599A (en) 1999-11-29
HRP20000740B1 (en) 2003-12-31
AR016482A1 (es) 2001-07-04
CA2331141A1 (en) 1999-11-18
PL194085B1 (pl) 2007-04-30
SK16822000A3 (sk) 2001-07-10
HUP0103536A2 (hu) 2002-07-29
TWI259835B (en) 2006-08-11
DE69902461D1 (de) 2002-09-12
IL139649A0 (en) 2002-02-10
DE69902461T2 (de) 2003-04-10
JP2002514645A (ja) 2002-05-21
CN1300287A (zh) 2001-06-20
HUP0102031A3 (en) 2002-10-28
NO20005712L (no) 2000-12-07
TR200003323T2 (tr) 2001-02-21
IL139649A (en) 2004-09-27
MY122147A (en) 2006-03-31
PT1077976E (pt) 2002-12-31
KR20010042852A (ko) 2001-05-25
NO319851B1 (no) 2005-09-19
CA2331187A1 (en) 1999-11-18
CA2331187C (en) 2008-11-18
TW572899B (en) 2004-01-21
NO319760B1 (no) 2005-09-12
US6448244B1 (en) 2002-09-10
HRP20000741A2 (en) 2001-06-30
IL139647A0 (en) 2002-02-10
DK1077976T3 (da) 2002-12-02
CZ298702B6 (cs) 2007-12-27
NZ507966A (en) 2002-10-25
JP2002514646A (ja) 2002-05-21
BG104933A (en) 2001-10-31
KR100593395B1 (ko) 2006-06-28
MY120248A (en) 2005-09-30
PL194086B1 (pl) 2007-04-30
HK1033312A1 (en) 2001-08-24
HUP0103536A3 (en) 2002-08-28
DE69907171D1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE200000225A (et) Arüüloksüalküüldialküülamiinid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
EE200200298A (et) Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04311B1 (et) Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090506